Stay updated on Sitravatinib Combo Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo Clinical Trial page.

Latest updates to the Sitravatinib Combo Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. Consequently, the study details and related sections are no longer visible and are replaced by the error page content.SummaryDifference18%

- Check20 days agoChange DetectedThe page's revision tag was updated to v3.7.0, replacing the previous v3.6.6 and indicating an updated version of the study documentation.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, signaling a small metadata update to the study record.SummaryDifference0.1%

- Check55 days agoChange DetectedResults were posted on 2026-08-04 for the study, adding a 'Results Posted' section with safety and outcome details, including the number of participants with treatment-related adverse events, treatment discontinuations due to AEs, and clinically significant laboratory abnormalities, along with the associated results dates and documents. The previous result measures such as 'Frequency of subjects experiencing treatment-related AEs' and 'Time to clinical or radiographic progression' were removed.SummaryDifference2%

- Check70 days agoChange DetectedThe page's revision reference was updated from v3.6.3 to v3.6.4, indicating a new revision of the page's template or metadata.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, signaling a new version of the page. This appears to be a maintenance update rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo Clinical Trial page.